- Home
- LFMDP
LFMDP
LifeMD Inc.
as of 08-19-2026 3:57pm EST
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 2012 |
| Target Price: | N/A | AVG Volume (30 days): | 1.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.37 | EPS Growth: | 141.67 |
| 52 Week Low/High: | $18.50 - $24.20 | Next Earning Date: | N/A |
| Revenue: | $12,468,578 | Revenue Growth: | 49.79% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -63.05 | Index: | N/A |
| Free Cash Flow: | 6.4M | FCF Growth: | N/A |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Aug 5, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLAug 5, 2026 · 100% conf.
1D
-0.12%
$23.47
Act: -1.11%
5D
-2.66%
$22.87
Act: +0.06%
20D
-6.09%
$22.07
Transcript text not available. View on SEC.gov →
2026 Q1 Q1 2026 Earnings
8-K May 6, 2026
Q1 2026 Earnings
8-KMay 6, 2026
2025 Q4 Q4 2025 Earnings
8-K Mar 9, 2026
Q4 2025 Earnings
8-KMar 9, 2026
Compare LFMDP vs Leading Stocks
See how LFMDP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LFMDP LifeMD Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.